A

    ArteraAI

    AI Native

    ArteraAI is a precision-medicine company that generates prognostic and predictive insights from digitized pathology images combined with clinical data to support treatment selection and risk stratification in localized prostate cancer.

    Est 2021|Valuation $400M|Raised $109.5M
    LinkedIn 7K|Web traffic 4K|FTEs 118